Credit Suisse’s Arrangement of Financing for Acquisition of DuPont Performance Coatings
September 05, 2012
On August 30, 2012, E. I. du Pont de Nemours and Company entered into a definitive agreement pursuant to which an affiliate of Carlyle Group L.P. will acquire its performance coatings unit for approximately $4.9 billion. Cravath represented Credit Suisse as a joint lead arranger of committed financing in connection with this transaction.
The Cravath team included partners Craig F. Arcella and Joseph D. Zavaglia and associates Brandon R. DeFrehn and Alexandra C. Orme.
Related Practices & Industries
People
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2004, Brooklyn Law SchoolValedictorian, summa cum laude
-
B.B.A., 2001, College of Insurancecum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
July 13, 2026
Boluda Towage’s €2.45 Billion Term Loan and Revolving Credit Facilities
Cravath represented the agent, mandated lead arrangers and lenders in connection with Boluda Towage’s €2.15 billion (equivalent) term loan facility and €300 million multi‑currency revolving credit facility. The proceeds will be used towards refinancing certain existing credit facilities and for general corporate purposes. Boluda Towage is a leading maritime services operator. The transaction closed on June 30, 2026.
Deals & Cases
April 06, 2026
Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
